ConductScience.org, home

Paper26917455

Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis.

Flamini V and 3 others. Crit Rev Oncol Hematol, 2016. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis. Papers, record 26917455. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26917455

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis.
PubMed
Journal
Crit Rev Oncol Hematol
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2018-12-02
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Flamini VValentina
2Jiang WGWen G
3Lane JJane
4Cui YXYu-Xin

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endothelial Progenitor CellsMajor topic
Neoplasm MetastasisMajor topic
Neovascularization, PathologicMajor topic
Breast Neoplasms
Carcinoma, Non-Small-Cell Lung
Female
Humans
Lung Neoplasms
Neoplasm Recurrence, Local
Ovarian Neoplasms
Prognosis
Signal Transduction
Tumor Microenvironment

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
39759554Endothelial progenitor cells as an angiogenic biomarker for the diagnosis and prognosis of lung cancer.Rep Pract Oncol Radiother2024https://conductscience.org/library/papers/39759554PubMed
37999904The role of host response to chemotherapy: resistance, metastasis and clinical implications.Clin Exp Metastasis2024https://conductscience.org/library/papers/37999904PubMed
36980704Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling.Cancers (Basel)2023https://conductscience.org/library/papers/36980704PubMed
36558070Chemical Constituents and Anti-Angiogenic Principles from a Marine Algicolous Penicillium sumatraense SC29.Molecules2022https://conductscience.org/library/papers/36558070PubMed
35203510Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View.Biomedicines2022https://conductscience.org/library/papers/35203510PubMed
34131419Differences in senescence of late Endothelial Progenitor Cells in non-smokers and smokers.Tob Induc Dis2021https://conductscience.org/library/papers/34131419PubMed
34063349Sweet Cherries as Anti-Cancer Agents: From Bioactive Compounds to Function.Molecules2021https://conductscience.org/library/papers/34063349PubMed
33449300To be or not to be: endothelial cell plasticity in development, repair, and disease.Angiogenesis2021https://conductscience.org/library/papers/33449300PubMed
33273969Role of the stromal cell derived factor-1 in the biological functions of endothelial progenitor cells and its underlying mechanisms.Exp Ther Med2021https://conductscience.org/library/papers/33273969PubMed
32239650Interleukin-1β augments the angiogenesis of endothelial progenitor cells in an NF-κB/CXCR7-dependent manner.J Cell Mol Med2020https://conductscience.org/library/papers/32239650PubMed
31802852Id-1 Promotes Reendothelialization In The Early Phase After Vascular Injury Through Activation Of NFkB/survivin Signaling Pathway.Drug Des Devel Ther2019https://conductscience.org/library/papers/31802852PubMed
31731627Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence.J Clin Med2019https://conductscience.org/library/papers/31731627PubMed
29732011Intravital microscopy in the study of the tumor microenvironment: from bench to human application.Oncotarget2018https://conductscience.org/library/papers/29732011PubMed
29545899Pro-apoptotic effect of TRAIL-transfected endothelial progenitor cells on glioma cells.Oncol Lett2018https://conductscience.org/library/papers/29545899PubMed
27504971miR-4443 Participates in the Malignancy of Breast Cancer.PLoS One2016https://conductscience.org/library/papers/27504971PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26917455

GET https://conductscience.org/api/papers/v1/26917455/authors